Cardiovascular disease is treated with a combination of lifestyle changes, medications, and, when necessary, procedures to restore blood flow to the heart. The specific approach depends on the type and severity of the condition, but nearly every treatment plan starts with the same foundation: managing blood pressure, lowering cholesterol, and reducing the heart’s workload. For many people, medications and dietary changes are enough. Others need stents or surgery to address blocked arteries directly.
Lifestyle Changes That Lower Risk
Before or alongside any medication, lifestyle modifications form the baseline of cardiovascular treatment. The American Heart Association recommends at least 150 minutes per week of moderate-intensity aerobic activity (like brisk walking, 30 minutes five days a week) or at least 75 minutes per week of vigorous activity. Regular exercise lowers blood pressure, improves how your body handles cholesterol, and reduces inflammation in blood vessels.
Diet plays an equally large role. The DASH eating plan, developed by the National Heart, Lung, and Blood Institute, targets the nutrients that directly affect blood pressure: potassium, calcium, magnesium, and fiber. A typical day on the plan includes 4 to 5 servings each of fruits and vegetables, 6 to 8 servings of whole grains, and limited saturated fat. Sodium is capped at 2,300 milligrams per day, though dropping to 1,500 milligrams lowers blood pressure even further. The Mediterranean diet follows similar principles, emphasizing fish, olive oil, nuts, and produce while limiting red meat and processed foods. Both patterns have strong evidence for reducing heart attacks and strokes over time.
Medications for Blood Pressure
High blood pressure forces the heart to work harder than it should, and over time that extra strain damages artery walls and thickens the heart muscle. Several classes of medication target blood pressure through different mechanisms, which is why many people end up taking more than one.
ACE inhibitors work by blocking a hormone that constricts blood vessels. This relaxes the arteries, reduces the resistance your heart pumps against, and lowers blood pressure. They also reduce inflammation and oxidative stress in blood vessel walls, which helps protect arteries beyond just the pressure drop. Beta-blockers take a different approach: they slow the heart rate and reduce the force of each contraction, which lowers both blood pressure and the heart’s oxygen demand. The slower heart rate also gives the heart more time between beats to receive its own blood supply, which is especially important when arteries are partially blocked. Calcium channel blockers relax blood vessel walls by preventing calcium from entering muscle cells in the arteries, causing them to widen.
For many patients, combining an ACE inhibitor with a beta-blocker addresses two different drivers of high blood pressure at once. ACE inhibitors are also particularly effective at protecting the kidneys, slowing the progression of kidney disease that often accompanies long-standing cardiovascular problems.
Cholesterol-Lowering Treatments
Statins remain the most widely prescribed medications for cardiovascular disease. They work by blocking an enzyme the liver needs to produce cholesterol, which forces the liver to pull more cholesterol out of the bloodstream. But statins do more than just lower cholesterol numbers. They also reduce inflammation inside artery walls, stabilize existing plaques so they’re less likely to rupture, and improve the function of the blood vessel lining. Common statins include atorvastatin, rosuvastatin, and simvastatin.
For people whose cholesterol stays stubbornly high despite maximum statin doses, or who can’t tolerate statins due to side effects like muscle pain, a newer class of injectable medications called PCSK9 inhibitors offers a powerful alternative. These drugs work by preserving receptors on liver cells that grab LDL cholesterol from the blood. In clinical trials, PCSK9 inhibitors reduced LDL cholesterol by 60% to 70% when used alone or added to statin therapy. In one major study of high-risk patients already on maximum statin doses, adding a PCSK9 inhibitor cut LDL by 61% compared to just 1% with a placebo. Interestingly, statins actually trigger the body to produce more of the protein that PCSK9 inhibitors block, which partially undermines their own effect. Combining the two essentially removes that counterbalance and amplifies LDL clearance.
Heart Failure Medications
Heart failure, where the heart can’t pump effectively enough to meet the body’s needs, requires its own set of treatments. The standard combination includes ACE inhibitors and beta-blockers (which reduce the heart’s workload), along with diuretics to remove excess fluid that builds up when the heart can’t keep pace.
One of the more surprising additions to heart failure treatment in recent years is a class of drugs originally designed for type 2 diabetes. These medications work by causing the kidneys to excrete more glucose in urine, but their benefits for the heart turned out to be significant and independent of blood sugar control. In clinical trials, they reduced hospitalizations for heart failure by roughly 30%. They’ve since been approved for treating heart failure with reduced pumping ability even in people who don’t have diabetes, and clinical guidelines now consider them a foundational therapy alongside the traditional medications.
Stenting and Angioplasty
When one or more coronary arteries are significantly blocked, a catheter-based procedure called percutaneous coronary intervention (PCI), commonly known as angioplasty with stenting, can restore blood flow without open surgery. A thin catheter with a small balloon at its tip is threaded through a blood vessel in the wrist or groin and guided to the blocked artery. The balloon is inflated at the narrowed site, compressing the plaque against the artery wall and reopening the passage. A small mesh tube called a stent is then left in place to keep the artery open.
Most stents used today are drug-eluting stents, coated with a medication that prevents the artery from narrowing again as scar tissue forms around the stent. Patients who receive these stents typically need to take two blood-thinning medications for at least three months to prevent clots from forming on the stent’s surface. For patients at high bleeding risk who can’t stay on that dual therapy, bare-metal stents without the drug coating are used instead.
PCI is the preferred treatment for heart attacks, unstable angina (chest pain that occurs unpredictably at rest), and certain other acute coronary events. In 5% to 10% of cases, the blockage is too complex for straightforward stenting, involving heavy calcification, total occlusion, or awkward anatomical locations. These cases require additional preparation techniques to modify the plaque before a stent can be placed.
Coronary Artery Bypass Surgery
When blockages are widespread or located in areas that stents can’t effectively treat, coronary artery bypass grafting (CABG) reroutes blood around the blocked sections using blood vessels harvested from elsewhere in the body. The most reliable graft is the left internal mammary artery, taken from inside the chest wall, which has become the gold standard for bypassing the most critical coronary artery (the left anterior descending) because of its excellent long-term durability and similarity to coronary arteries. Surgeons also use the radial artery from the forearm and the saphenous vein from the leg.
Traditional CABG requires opening the chest through the breastbone and temporarily stopping the heart while a heart-lung machine takes over circulation. Newer approaches have reduced the invasiveness of the procedure. Off-pump bypass performs the surgery on a beating heart, avoiding the heart-lung machine entirely. Minimally invasive techniques use smaller incisions between the ribs rather than splitting the breastbone. For patients with disease in multiple vessels, hybrid procedures combine bypass surgery on the most critical artery with stenting for less severe blockages, reducing the extent of surgery needed.
Cardiac Rehabilitation
After a heart attack, stenting, or bypass surgery, cardiac rehabilitation is a structured program that combines supervised exercise, education, and counseling to help you recover and reduce the chance of future events. Programs typically run 12 weeks and involve monitored exercise sessions two or three times per week, where intensity is gradually increased based on your heart’s response. You’ll also work with dietitians on eating patterns and learn to recognize warning signs that need attention. The exercise component is carefully tailored: staff monitor your heart rate, blood pressure, and symptoms during each session to keep you in a safe range while building cardiovascular fitness. Completing a full cardiac rehab program significantly lowers the risk of another cardiac event and improves both physical capacity and quality of life.